$1,106.21
Value $490B
COST and GRDN stock compared: price, dividend, valuation and results, from SEC filings.
$1,106.21
Value $490B
$49.52
Value $3.1B
Costco Wholesale (COST) has a market value of $490B and Guardian Pharmacy Services (GRDN) $3.1B. Over the last year, with dividends, COST moved +21.7% and GRDN +57.0%. The P/E is 53.1 for COST and 42.0 for GRDN. Dividend yield: COST 0.52%, GRDN none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
COST$490B
GRDN$3.1B
COST is 156 times GRDN
Revenue, 12 months
COST$303B
GRDN$1.5B
COST is 208 times GRDN
Net income, 12 months
COST$9.2B
GRDN$75M
COST is 123 times GRDN
Operating margin
COST3.9%
GRDN6.5%
2.6 points apart
ROIC
COST24.3%
GRDN28.8%
4.5 points apart
P/E
COST53.1
GRDN42.0
COST is 1.3 times GRDN
Dividend yield
COST0.5%
GRDN0.0%
0.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
COST+21.7%
GRDN+57.0%
| Period | COSTWith dividends | GRDNWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +21.7%Price +21.0% | +57.0%Price +57.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
COSTCostco WholesaleGRDNGuardian Pharmacy Services
| Price | $1,106.21 | $49.52 |
|---|---|---|
| Market value | $490B | $3.1B |
| Enterprise value (EV) | $476B | $3.0B |
| P/E | 53.1 | 42.0 |
| P/E, 5-year median | 45.5 | – |
| P/B | 13.7 | 11.2 |
| EV/EBIT | 40.8 | 32.1 |
| Free cash flow yield | 1.9% | 2.8% |
| Revenue, 12 months | $303B | $1.5B |
|---|---|---|
| Net income, 12 months | $9.2B | $75M |
| Free cash flow, 12 months | $9.4B | $87M |
| Earnings per share, 12 months | $20.76 | $1.18 |
| Revenue growth, year on year | 10.1% | 17.9% |
| Revenue growth a year, past | +9.1%over 5 years | +17.9%over 1 years |
| EPS growth a year, past | +13.0%over 5 years | – |
| Gross margin | 12.8% | 22.5% |
|---|---|---|
| Operating margin | 3.9% | 6.5% |
| Net margin | 3.0% | 5.1% |
| ROIC | 24.3% | 28.8% |
| ROE | 28.7% | 31.6% |
| Cash | $21.3B | $120M |
|---|---|---|
| Total debt | $10.2B | $36M |
| Net debt / EBITDA | -1.0 | -1.0 |
| Interest cover | 80.6× | 145.3× |
| Dividend yield | 0.5% | – |
|---|---|---|
| Dividend per share, 12 months | $5.71 | – |
| Dividend growth a year, past | +13.1%over 4 years | – |
| Buyback yield | 0.2% | – |
| Shareholder yield | 0.7% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Costco Wholesale ($490B) is about 156.2 times Guardian Pharmacy Services ($3.1B), at today's prices.
Since November 12, 2025, COST's price moved +21.0% and GRDN's +57.0%. With dividends: COST +21.7% (+21.7% a year), GRDN +57.0% (+57.0% a year). Past returns do not predict future ones.
The dividend yield at today's price is 0.52% for Costco Wholesale and none for Guardian Pharmacy Services. Over the last twelve months they paid $5.71 and – per share.
At today's price, the P/E is 53.1 for COST and 42.0 for GRDN. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 3.0% for Costco Wholesale and 5.1% for Guardian Pharmacy Services, and the operating margin 3.9% and 6.5%. Revenue was $303B and $1.5B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.